Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE: 603392)
Health Care · Biotechnology · CN
CN¥30.59
+1.63% today · -50.9% 1Y
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE: 603392) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.75B and employs 4,116 people.
Over the last twelve months the share price has lost 50.9%, trading between 25.58 and 62.56.
Tweenvest scores Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. across four factors: quality 65/100, value 58/100, growth 0/100. Its strongest factor is quality.
603392 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.75B
- Revenue (TTM)
- $297.94M
- P/E
- —
- EPS
- -0.30
- Dividend yield
- —
- Beta (5Y)
- 0.75
- 52-week high
- CN¥62.56
- 52-week low
- CN¥25.58
- Avg volume (3M)
- —
- Shares outstanding
- 1.26B
- Employees
- 4,116
- Next earnings
- —
About Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
- ISIN
- CNE100004090
- Founded
- 1991
- Listed since
- Apr 29, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.83 | +14.36% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.